Structures by: Portalone G.
Total: 66
6-Methyluracil
C5H6N2O2
IUCrData (2019) 4, 6 x190861
a=20.572(3)Å b=3.9052(5)Å c=14.811(3)Å
α=90° β=110.95(2)° γ=90°
C4H3N3O4,C4H4FN3O,2(H2O)
C4H3N3O4,C4H4FN3O,2(H2O)
Chemistry Central Journal (2011) 5, 51
a=10.2066(6)Å b=28.2758(11)Å c=4.7187(3)Å
α=90.00° β=111.293(6)° γ=90.00°
C4H6N3O,C4H3N3O4,C4H5N3O,C4H2N3O4,2(H2O)
C4H6N3O,C4H3N3O4,C4H5N3O,C4H2N3O4,2(H2O)
Chemistry Central Journal (2011) 5, 51
a=12.7424(9)Å b=17.4112(7)Å c=21.0833(10)Å
α=90.00° β=90.00° γ=90.00°
Thymine
C5H6N2O2
Acta Chemica Scandinavica (1999) 53, 57-68
a=12.889(7)Å b=6.852(3)Å c=6.784(3)Å
α=90° β=104.92(5)° γ=90°
Co ((C H3) P O3) (H2 O)
CH3CoO4P
Journal of Solid State Chemistry (2006) 179, 389-397
a=17.413Å b=4.7856Å c=5.6638Å
α=90° β=90° γ=90°
C22H16N2O2
C22H16N2O2
Organic & biomolecular chemistry (2020) 18, 16 3177-3189
a=5.6311(5)Å b=16.1768(13)Å c=18.5883(14)Å
α=90° β=90.132(7)° γ=90°
C24H18N2O2S
C24H18N2O2S
Organic & biomolecular chemistry (2020) 18, 16 3177-3189
a=6.5760(4)Å b=16.9049(10)Å c=17.5937(8)Å
α=90° β=90° γ=90°
C23H18N2O2
C23H18N2O2
Organic & biomolecular chemistry (2020) 18, 16 3177-3189
a=19.7918(6)Å b=8.1770(2)Å c=24.1081(7)Å
α=90° β=107.785(3)° γ=90°
C22H20CoN8O2,2(Cl),2(H2O)
C22H20CoN8O2,2(Cl),2(H2O)
Med. Chem. Commun. (2017) 8, 1 103
a=21.752(3)Å b=10.0815(9)Å c=13.905(2)Å
α=90° β=124.39(2)° γ=90°
C11H10N4S
C11H10N4S
Med. Chem. Commun. (2017) 8, 1 103
a=8.9464(9)Å b=12.8728(11)Å c=9.7816(7)Å
α=90° β=95.947(8)° γ=90°
C22H18CoN8S2,ClO4,C2OS
C22H18CoN8S2,ClO4,C2OS
Med. Chem. Commun. (2017) 8, 1 103
a=10.3016(6)Å b=10.5421(7)Å c=14.5516(10)Å
α=80.662(6)° β=89.829(5)° γ=65.733(6)°
C22H18CoN8Se2,ClO4,C2OS
C22H18CoN8Se2,ClO4,C2OS
Med. Chem. Commun. (2016) 7, 8 1604
a=10.3102(6)Å b=10.7772(6)Å c=14.5496(8)Å
α=80.932(5)° β=89.859(5)° γ=65.526(5)°
C11H10N4Se
C11H10N4Se
Med. Chem. Commun. (2016) 7, 8 1604
a=8.8291(8)Å b=12.9308(8)Å c=10.1657(7)Å
α=90° β=97.384(8)° γ=90°
C18H15KO8,H2O
C18H15KO8,H2O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 47 14337-14344
a=9.7482(7)Å b=10.2754(9)Å c=10.5529(9)Å
α=114.473(8)° β=108.182(7)° γ=95.313(7)°
2,6-Dimethoxybenzic acid.
C9H10O4
Acta Crystallographica Section E (2020) 76, 12 1823-1826
a=7.7574(10)Å b=8.4763(10)Å c=14.3322(19)Å
α=90° β=97.526(12)° γ=90°
P-Bromoaniline hydrochloride
C6H7BrN,Cl
Acta Crystallographica Section E (2005) 61, 9 o3083-o3085
a=8.629(2)Å b=9.784(2)Å c=9.863(9)Å
α=90° β=105.61(5)° γ=90°
N-phenylimidocarbonimidic diamide hydrochloride
C8H12N51,Cl1
Acta Crystallographica Section E (2004) 60, 7 o1165-o1166
a=9.3421(14)Å b=6.6804(11)Å c=17.297(6)Å
α=90.00° β=106.82(2)° γ=90.00°
5-fluorocytosine monohydrate
C4H4FN3O,H2O
Acta Crystallographica Section E (2006) 62, 3 o1049-o1051
a=7.5142(11)Å b=9.4241(16)Å c=17.692(6)Å
α=90° β=99.16(2)° γ=90°
C9H16N4O2,2H2O
C9H16N4O2,2H2O
Acta Crystallographica Section C (1995) 51, 9 1844-1846
a=8.871(2)Å b=7.397(2)Å c=20.393(4)Å
α=90° β=93.83(2)° γ=90°
C7H13N3O
C7H13N3O
Acta Crystallographica Section C (1994) 50, 4 635-638
a=7.3460(10)Å b=10.6320(10)Å c=11.9860(10)Å
α=64.850(10)° β=88.310(10)° γ=89.310(10)°
C6H11NO5S
C6H11NO5S
Acta Crystallographica Section C (1993) 49, 5 976-978
a=6.1040(10)Å b=8.933(3)Å c=16.062(3)Å
α=90.0° β=90.0° γ=90.0°
5-[3-(Dimethylamino)propyl]-10,11-dihydro-5<i>H</i>-dibenzo[a,d][7]annulen-5-ol
C20H25NO
Acta Crystallographica Section E (2007) 63, 2 o746-o747
a=7.7278(12)Å b=27.744(3)Å c=8.6183(15)Å
α=90.00° β=113.841(10)° γ=90.00°
Nicotinohydrazide
C6H7N3O
Acta Crystallographica Section E (2008) 64, 1 o304-o304
a=3.8727(10)Å b=10.481(2)Å c=15.855(2)Å
α=90.00° β=90.00° γ=90.00°
5-iodouracil
C4H3IN2O2
Acta Crystallographica Section E (2008) 64, 2 o365-o365
a=4.89650(18)Å b=4.45921(13)Å c=14.2167(2)Å
α=90° β=92.341(2)° γ=90°
(3R,5S)-5(3)-carboxy-3,4,5,6-tetrahydro-2<i>H</i>-1,4-thiazin-4-ium- 3(5)-carboxylate
C6H9NO4S
Acta Crystallographica Section E (2008) 64, 3 o636
a=6.1641(8)Å b=9.3230(10)Å c=12.7600(10)Å
α=90.00° β=90.00° γ=90.00°
Orotic acid monohydrate, vitamin B~13~
C5H4N2O4,H2O
Acta Crystallographica Section E (2008) 64, 4 o656
a=5.89854(14)Å b=6.92921(15)Å c=9.59160(18)Å
α=74.6778(12)° β=72.3232(16)° γ=68.447(2)°
Biguanidinium dichloride
C2H9N52,2(Cl)
Acta Crystallographica Section E (2008) 64, 4 o683
a=6.43693(9)Å b=16.93420(18)Å c=6.65260(8)Å
α=90.00° β=98.6878(12)° γ=90.00°
3-deazauracil
C5H5NO2
Acta Crystallographica Section E (2008) 64, 6 o1107-o1108
a=5.33930(10)Å b=8.64540(10)Å c=11.2652(2)Å
α=90.00° β=90.00° γ=90.00°
C4H5N3O
C4H5N3O
Acta Crystallographica Section E (2007) 63, 4 o1869-o1871
a=8.7211(6)Å b=11.4222(8)Å c=10.5027(9)Å
α=90.00° β=94.605(14)° γ=90.00°
2,4-diamino-1,3,5-triazine
C3H5N5
Acta Crystallographica Section E (2007) 63, 7 o3232-o3232
a=9.8631(9)Å b=3.7180(3)Å c=12.9609(9)Å
α=90.00° β=99.643(9)° γ=90.00°
Acetoguanamine <i>N</i>,<i>N</i>-dimethylformamide solvate
C4H7N5,C3H7NO
Acta Crystallographica Section E (2008) 64, 9 o1685
a=25.548(2)Å b=23.0626(19)Å c=7.2689(9)Å
α=90° β=90° γ=90°
Benzamidinium tetrahydropentaborate sesquihydrate
C7H9N2,B5H4O10,1.5(H2O)
Acta Crystallographica Section E (2008) 64, 7 o1282-o1283
a=8.22314(19)Å b=10.7814(2)Å c=19.1997(3)Å
α=75.9475(11)° β=85.4458(16)° γ=73.6979(13)°
Ammonium oxalate oxalic acid dihydrate
H4N,C2HO4,C2H2O4,2H2O
Acta Crystallographica Section E (2006) 62, 10 o4725-o4727
a=6.3387(8)Å b=7.2227(9)Å c=10.5527(11)Å
α=94.172(10)° β=100.274(10)° γ=97.704(10)°
Benzamidinidium 2,6-dimethoxybenzoate
C7H9N2,C9H9O4
Acta Crystallographica Section C (2012) 68, 11 o447-o451
a=9.89210(10)Å b=10.44710(10)Å c=15.1403(2)Å
α=90.00° β=90.000° γ=90.00°
Benzamidinidium 2,6-dimethoxybenzoate
C7H9N2,C9H9O4
Acta Crystallographica Section C (2012) 68, 11 o447-o451
a=14.7103(2)Å b=11.71740(10)Å c=19.7281(3)Å
α=90.00° β=109.145(2)° γ=90.00°
Cytosine--5-fluorouracil--water (1/1/1)
C4H5N3O,C4H3FN2O2,H2O
Acta Crystallographica Section C (2007) 63, 7 o423-o425
a=4.26290(10)Å b=9.5372(5)Å c=13.9639(9)Å
α=102.562(5)° β=91.055(7)° γ=101.331(7)°
2,4-diamino-6-methyl-1,3,5-triazin-1-ium chloride 2,4-diamino-6-methyl-1,3,5-triazine monohydrate
C4H8N5,Cl,C4H7N5,H2O
Acta Crystallographica Section C (2007) 63, 11 o655-o658
a=7.3808(9)Å b=9.4538(10)Å c=10.3942(9)Å
α=90.971(12)° β=101.554(14)° γ=104.252(16)°
Triaminopyrimidinediium dichloride dihydrate
C4H9N52,2(Cl),2(H2O)
Acta Crystallographica Section C (2007) 63, 11 o655-o658
a=9.4045(10)Å b=8.6089(9)Å c=13.7420(12)Å
α=90.00° β=107.742(10)° γ=90.00°
5-Formyluracil
C5H4N2O3
Acta Crystallographica Section C (2007) 63, 11 o650-o654
a=6.2840(5)Å b=6.7050(6)Å c=12.8302(9)Å
α=90.00° β=90.00° γ=90.00°
Benzamidinium 3-methoxybenzoate
C7H9N2,C8H7O3
Acta Crystallographica Section C (2014) 70, 2 225-229
a=9.4532(9)Å b=6.1789(8)Å c=24.906(3)Å
α=90.00° β=96.513(11)° γ=90.00°
Benzamidinium 4-methoxybenzoate
C7H9N2,C8H7O3
Acta Crystallographica Section C (2014) 70, 2 225-229
a=9.4676(7)Å b=6.8888(6)Å c=21.7018(12)Å
α=90.00° β=92.4498(7)° γ=90.00°
Benzamidinium 3,4,5-trimethoxybenzoate monohydrate
C7H9N2,C10H11O5,H2O
Acta Crystallographica Section C (2014) 70, 2 225-229
a=22.8771(15)Å b=7.8631(3)Å c=23.1789(13)Å
α=90.00° β=117.515(8)° γ=90.00°
Benzamidinidium orotate hemihydrate
C7H9N2,C5H3N2O4,0.5H2O
Acta Crystallographica Section C (2010) 66, 6 o295-o301
a=27.2046(6)Å b=7.3566(2)Å c=12.6687(3)Å
α=90.00° β=91.621(2)° γ=90.00°
Benzamidinium isoorotate trihydrate
C7H9N2,C5H3N2O4,3H2O
Acta Crystallographica Section C (2010) 66, 6 o295-o301
a=11.3562(2)Å b=6.04020(10)Å c=22.3763(4)Å
α=90.00° β=96.221(2)° γ=90.00°
Benzamidinium diliturate dihydrate
C7H9N2,C4H2N3O5,2H2O
Acta Crystallographica Section C (2010) 66, 6 o295-o301
a=10.7607(3)Å b=5.0998(2)Å c=27.2412(5)Å
α=90.00° β=98.2485(11)° γ=90.00°
Benzamidinidium 5-nitrouracilate
C7H9N2,C4H2N3O4
Acta Crystallographica Section C (2010) 66, 6 o295-o301
a=4.3625(4)Å b=10.4461(11)Å c=13.8556(12)Å
α=78.551(7)° β=86.841(8)° γ=84.051(7)°
13,21,35,43-tetramethyl-3,6,9,17,25,28,31,39,46,49- decaoxaheptacyclo[21.21.3^1,23^.3^11,33^.0^2,41^.0^10,15^.0^19,24^.0^32,37^] pentaconta-1,10,12,14,19,21,23,32,34,36,41,43-dodecaene
C44H52O10
Acta Crystallographica Section C (2002) 58, 6 o345-o346
a=29.982(5)Å b=14.154(3)Å c=27.612(2)Å
α=90° β=137.36(3)° γ=90°
1-phenylbiguanidium 5-nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate monohydrate
C8H12N5,C4H2N3O5,H2O
Acta Crystallographica Section C (2007) 63, 3 o181-o184
a=11.387(2)Å b=12.135(3)Å c=13.804(3)Å
α=97.48(3)° β=106.37(3)° γ=116.39(4)°
2,6-dimethoxybenzoic acid
C9H10O4
Acta Crystallographica Section E (2009) 65, 2 o327-o328
a=7.12255(13)Å b=8.92296(15)Å c=13.79430(18)Å
α=90.00° β=90.00° γ=90.00°
2-nitrobenzoic acid
C7H5NO4
Acta Crystallographica Section E (2009) 65, 5 o954
a=5.0147(15)Å b=7.527(2)Å c=10.620(2)Å
α=69.41(2)° β=86.07(2)° γ=71.01(3)°
4-Methoxybenzamidinium 2,6-dimethoxybenzoate
C8H11N2O,C9H9O4
Acta Crystallographica Section E (2012) 68, 2 o268-o269
a=12.6594(3)Å b=9.6754(2)Å c=13.7923(4)Å
α=90.00° β=99.241(2)° γ=90.00°
Benzamidinium 2-methoxybenzoate
C7H9N2,C8H7O3
Acta Crystallographica Section E (2013) 69, 7 o1114-o1115
a=7.5154(3)Å b=9.1393(4)Å c=11.6498(5)Å
α=69.612(3)° β=80.500(5)° γ=72.482(4)°
4-Methoxybenzamidinium chloride monohydrate
C8H11N2O1,Cl1,H2O
Acta Crystallographica Section E (2012) 68, 11 o3083
a=11.3029(7)Å b=9.3142(5)Å c=9.9983(6)Å
α=90.00° β=99.820(6)° γ=90.00°
4-Methoxybenzamidinium acetate
C8H11N2O,C2H3O2
Acta Crystallographica Section E (2012) 68, 12 o3277
a=8.7591(14)Å b=6.5478(8)Å c=19.456(3)Å
α=90.00° β=102.580(14)° γ=90.00°
Cytosinium orotate dihydrate
C4H6N3O,C5H3N2O4,2(H2O)
Acta Crystallographica Section E (2013) 69, 1 o14-o15
a=5.1486(2)Å b=15.1631(6)Å c=16.4206(7)Å
α=90.00° β=90.562(3)° γ=90.00°
4-Methoxybenzamidinium bromide
C8H11N2O,Br
Acta Crystallographica Section E (2013) 69, 1 o56
a=7.5657(6)Å b=10.8711(7)Å c=11.5419(7)Å
α=90.00° β=90.00° γ=90.00°
2,6-dimethoxybenzoic acid
C9H10O4
Acta Crystallographica Section E (2011) 67, 12 o3394-o3395
a=8.1423(3)Å b=8.1423(3)Å c=27.6814(18)Å
α=90.00° β=90.00° γ=90.00°
4-Methoxybenzamidinium hydrogen sulfate
C8H11N2O,HO4S
Acta Crystallographica Section E (2012) 68, 11 o3244
a=14.2608(14)Å b=10.1844(9)Å c=7.5723(9)Å
α=90.00° β=94.206(10)° γ=90.00°
4-Methoxybenzamidinium nitrate
C8H11N2O,NO3
Acta Crystallographica Section E (2012) 68, 12 o3334
a=7.1049(7)Å b=10.3558(8)Å c=13.4325(9)Å
α=90.00° β=90.00° γ=90.00°
4-Methoxybenzamidinium hydrogen oxalate monohydrate
C8H11N2O,C2HO4,H2O
Acta Crystallographica Section E (2012) 68, 12 o3350-o3351
a=7.1444(8)Å b=9.0428(7)Å c=18.115(2)Å
α=90.00° β=93.156(10)° γ=90.00°
C6H4NiO4P
C6H4NiO4P
Inorganic Chemistry (2008) 47, 10945-10952
a=5.54853(19)Å b=14.3919(5)Å c=4.79766(13)Å
α=90.00° β=90.00° γ=90.00°
C2H9ClCrNO4P
C2H9ClCrNO4P
Inorganic Chemistry (2003) 42, 6345-6351
a=5.249(1)Å b=14.133(3)Å c=5.275(1)Å
α=90.00° β=105.55(2)° γ=90.00°
CH5FeO4P
CH5FeO4P
Inorganic Chemistry (2002) 41, 709-714
a=17.538(2)Å b=4.8140(9)Å c=5.719(1)Å
α=90.00(0)° β=90.00(0)° γ=90.00(0)°
Chromium(II) Methyl Phosphonate Dihydrate
CH5CrO5P
Inorganic Chemistry (2010) 49, 7472-7477
a=4.4714(5)Å b=6.8762(7)Å c=19.180(2)Å
α=90.00° β=90.00° γ=90.00°
C42H38Al2N4O6,2(CH4O)
C42H38Al2N4O6,2(CH4O)
Inorganic chemistry (2007) 46, 22 9057-9059
a=10.6865(11)Å b=15.0442(19)Å c=12.5046(17)Å
α=90.00° β=91.703(16)° γ=90.00°
C24H22AlN2O5
C24H22AlN2O5
Inorganic chemistry (2007) 46, 22 9057-9059
a=9.13560(50)Å b=11.40230(80)Å c=11.64000(80)Å
α=86.1385(34)° β=69.3368(34)° γ=78.0562(37)°